Technology | May 26, 2009

Mentice Offers VIST Enhanced Carotid, Coronary 7.7 Training Modules


The new and enhanced VIST Enhanced Carotid and Coronary 7.7 training modules, from Mentice, feature vital signs, complications, medication management and measurement functionality enhance to create clinical realism and elevate the educational value of simulation training. The system includes new patient cases, including chronic total occlusion and transradial access. The company said these cases challenge the learner to modify previously acquired skills to meet new procedural objectives. ?? The system offers vital signs recognition and response. ECG signals are derived from a model that recognizes a lack of oxygen supply to the heart. Any action that reduces oxygen supply will create changes in the ECG read out, requiring a trainee response. A select number of cases present complications that will occur as a result of trainee actions. For example, inserting a catheter too deeply into an ostium could result in spasm. Other complications are dissection, bradycardia and hypotension. Medication administration is now included to manage the complications the trainees encounter. Multiple cognitive decisions are required in this functionality, such as what medication, how much and how often. New measurement functionality allows the trainee to measure thing such as the diameter and length of lesions and reference vessels.

 


Related Content

Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65 ...

Home October 29, 2025
Home
News | Cath Lab

Oct. 25, 2025 — Medtronic plc has announced the launch of the Stedi Extra Support guidewire, designed to enhance ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 27, 2025 — Elixir Medical, a developer of technologies to treat cardiovascular disease, has announced new clinical ...

Home October 28, 2025
Home
News | Cath Lab

Oct. 22, 2025 — Heartflow, Inc. has introduced Heartflow PCI Navigator, the newest addition to the Heartflow One ...

Home October 23, 2025
Home
News | Cath Lab

Oct. 15, 2025 — Stereotaxis recently announced it has obtained CE Mark in Europe and submitted a 510(k) application to ...

Home October 16, 2025
Home
News | Cath Lab

Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...

Home October 07, 2025
Home
News | Cath Lab

Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...

Home September 23, 2025
Home
Subscribe Now